SDS3 Inhibitors refer to a specialized category of chemical compounds designed to target and modulate the activity of SDS3, also known as Sin3A-associated protein 30 (SAP30)-like protein. SDS3 is a protein that is a part of larger complexes involved in chromatin remodeling and gene regulation. Specifically, it is a component of the Sin3 histone deacetylase (HDAC) complex, which plays a crucial role in modifying chromatin structure by removing acetyl groups from histone proteins. This modification leads to gene repression, influencing the transcriptional activity of specific genes. SDS3, as part of the Sin3 complex, contributes to the recruitment of HDAC enzymes to target genes, thereby regulating their expression.
Structurally, SDS3 Inhibitors are carefully designed molecules that interact with SDS3, potentially disrupting its function within the Sin3 complex. By binding to SDS3, these inhibitors can hinder its ability to recruit HDAC enzymes, consequently affecting histone deacetylation and gene expression. This modulation can have a broad impact on the regulation of various genes, making SDS3 inhibitors valuable tools for researchers studying chromatin remodeling, gene expression, and epigenetic regulation. Understanding the role of SDS3 and its modulation by inhibitors contributes to the broader knowledge of the intricate mechanisms underlying gene regulation and epigenetic control within cells.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is a pan-HDAC inhibitor and might affect SDS3 by inhibiting the entire HDAC complex. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This is a well-known HDAC inhibitor that can potentially influence SDS3 function by targeting the HDAC complex. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Romidepsin inhibits HDACs and might indirectly affect SDS3 function. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
As a pan-HDAC inhibitor, panobinostat might influence SDS3 by inhibiting the HDAC complex. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
This HDAC inhibitor could potentially affect SDS3 function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
This compound inhibits HDACs and might indirectly influence SDS3. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Although primarily an anticonvulsant, valproic acid has HDAC inhibitory activity and could affect SDS3. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
This short-chain fatty acid has HDAC inhibitory properties and might influence SDS3. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
Mocetinostat is a HDAC inhibitor that might have an effect on SDS3. | ||||||
ITF2357 | 732302-99-7 | sc-364513 sc-364513A | 5 mg 50 mg | $340.00 $1950.00 | ||
As an HDAC inhibitor, givinostat could potentially influence SDS3 function. | ||||||